investigating virus-related cancers with a focus on Human papillomavirus (HPV)
Research in the Zehbe lab focuses on the relationship between HPV and cancer, covering the entire cancer continuum: including basic research, non-invasive therapies as well as prevention and screening.
Both men and women can be carriers of human papillomavirus (HPV). Infection with HPV is normally taken care of by the host's immune surveillance. HPV is NOT a disease per se and virtually all of us will be infected at some point in life. However, some individuals develop persistent infections. Depending on the strain of HPV, these persistent infections can lead to benign (genital and skin warts) or malignant lesions (e.g. cervical cancer as well as anogenital and head and neck cancers).
Both men and women can be carriers of human papillomavirus (HPV). Infection with HPV is normally taken care of by the host's immune surveillance. HPV is NOT a disease per se and virtually all of us will be infected at some point in life. However, some individuals develop persistent infections. Depending on the strain of HPV, these persistent infections can lead to benign (genital and skin warts) or malignant lesions (e.g. cervical cancer as well as anogenital and head and neck cancers).
Left to Right: Dr. Robert Jackson, Mehran Masoom, Dr. Guillem Dayer, Dr. Ingeborg Zehbe, Statton Eade, Dallas Nygard, Dr. Melissa Togtema
|
Ingeborg Zehbe, PhD, DSc LU/TBRHRI Research Chair & Senior Scientist |
Probe Development & Biomarker Exploration
Thunder Bay Regional Health Research Institute 980 Oliver Road Thunder Bay, ON Canada, P7B 6V4 |
Last updated on 30 May 2019